Spreadsheet: 8f481f03-8ddd-4eec-9e77-66a7be9b70f4
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
FMEPL | Test | FMEPL | Meningoencephalitis (Encephalitis) Panel, CSF | Meningoencephalitis Panel CSF | Enzyme-linked Immunosorbent Assay (ELISA) Immunofluorescence Assay (IFA) Enzyme Immunoassay (EIA) |  |  |  | 5 | mL | Submit 5 mL spinal fluid (CSF). Refrigerate specimen after collection, and ship at refrigerate temperature. | 2.7 mL | Hemolysis	NA Thawing	Warm reject; Cold OK Lipemia	NA Icterus	NA Other	NA | Meningoencephalitis (Encephalitis) Panel (CSF)   Mumps Antibody Panel, IFA (CSF)   Reference Range:  IgG  <1:8                             IgM  <1:1   Diagnosis of infections of the central nervous system can be accomplished by demonstrating the presence of intrathecally-produced specific antibody. Interpretation of results may be complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps.  The interpretation of CSF results must consider CSF-serum antibody ratios to the infectious agent.   This assay was developed and its performance characteristics have been determined by Focus Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.   Lymphocytic Choriomeningitis (LCM) [NAME], IFA (CSF)   Reference Range:  IgG  <1:1                             IgM  <1:1   Interpretive Criteria: <1:1  Antibody Not Detected                       > or = 1:1  Antibody Detected   Diagnosis of infections of the central nervous system can be accomplished by demonstrating the presence of intrathecally-produced specific antibody. However, interpreting results is complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps.   This assay was developed and its performance characteristics determined by Focus Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.   Eastern Equine Encephalitis Virus Antibody, IFA (CSF)   Reference Range:  IgG  <1:4                             IgM  <1:4   NOTE: Specimens positive for arbovirus antibody are CDC reportable. Please contact your local public health agency.   Diagnosis of infections of the central nervous system can be accomplished by demonstrating the presence of intrathecally-produced specific antibody. However, interpreting results is complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps. The interpretation of CSF results must consider CSF-serum antibody ratios to the infectious agent.   California Encephalitis Virus Antibody Panel, IFA (CSF)   Reference Range:  IgG  <1:4                             IgM  <1:4   NOTE: Specimens positive for arbovirus antibody are CDC reportable. Please contact your local public health agency.   Diagnosis of infections of the central nervous system can be accomplished by demonstrating the presence of intrathecally-produced specific antibody. However, interpreting results is complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps. The interpretation of CSF results must consider CSF-serum antibody ratios to the infectious agent.   St. Louis Encephalitis Virus Antibody, IFA (CSF)   Reference Range:  IgG  <1:4                             IgM  <1:4   NOTE: Specimens positive for arbovirus antibody are CDC reportable. Please contact your local public health agency.   Diagnosis of infections of the central nervous system can be accomplished  by demonstrating the presence of intrathecally-produced specific antibody. However, interpreting results is complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps. The interpretation of CSF results must consider CSF-serum antibody ratios to the infectious agent.   Western Equine Encephalitis IgG & IgM Ab Pnl, IFA (CSF)   Reference Range:  IgG  <1:4                             IgM  <1:4   NOTE: Specimens positive for arbovirus antibody are CDC reportable. Please contact your local public health agency.   Diagnosis of infections of the central nervous system can be accomplished by demonstrating the presence of intrathecally-produced specific antibody. However, interpreting results is complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps. The interpretation of CSF results must consider CSF-serum antibody ratios to the infectious agent.   West Nile Virus Antibodies (IgG, IgM), CSF   Reference Range:  IgG <1.30                             IgM <0.90   Interpretive Criteria: IgG:              <1.30  Antibody not detected                                                  1.30 - 1.49  Equivocal                                                  >=1.50  Antibody detected                                IgM:             <0.90  Antibody not detected                                                  0.90 - 1.10  Equivocal                                                  >1.10  Antibody detected   West Nile Virus (WNV) IgM is usually detectable in CSF from WNV-infected patients with encephalitis or meningitis at the time of clinical presentation. Because IgM antibody does not readily cross the blood-brain barrier, IgM antibody in CSF strongly suggests acute central nervous system infection. WNV antibody results from CSF should be interpreted with caution. Possible complicating factors include low levels of antibody found in CSF, passive transfer of antibodies from blood, and contamination via bloody spinal taps. Antibodies induced by other Flavivirus infections (e.g. Dengue virus, St. Louis encephalitis virus) may show cross-reactivity with WNV.   WNV antibody results for CSF should be interpreted with caution. Complicating factors include low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps.   Herpes Simplex Virus 1/2 (IgG) Type Specific Antibodies, CSF   Reference Range: < or = 1.00   Interpretive Criteria: < or = 1.00  Antibody not detected                                     > 1.00  Antibody detected   Detection of HSV type-specific IgG in CSF may indicate central nervous system (CNS) infection by that HSV type. However, interpretation of results may be complicated by a number of factors, including low antibody levels found in CSF, passive transfer of antibody across the blood-brain barrier, and serum contamination of CSF during CSF collection. PCR detection of type-specific HSV DNA in CSF is the preferred method for identifying HSV CNS infections.     Herpes Simplex Virus 1/2 Antibody (IgM), IFA with [NAME] to Titer, CSF   Reference Range:  Negative   The IFA procedure for measuring IgM antibodies to HSV 1 and HSV 2 detects both type-common and type-specific HSV antibodies. Thus, IgM reactivity to both HSV 1 and HSV 2 may represent crossreactive HSV antibodies rather than exposure to both HSV 1 and HSV 2.   Diagnosis of central nervous system infections can be accomplished by demonstrating the presence of intrathecally-produced specific antibody. Interpreting results may be complicated by low antibody levels found in CSF, passive transfer of antibody from blood, and contamination via bloody taps. The interpretation of CSF results must consider CSF-serum antibody ratios to the infectious agent.   This test was developed and its performance characteristics have been determined by Focus Diagnostics. Performance characteristics refer to the analytical performance of the test.   Test Performed by: Focus Diagnostics, Inc.                              5785 Corporate Avenue                              Cypress, CA 90630-4750 | Monday through Saturday | 1 - 4 days | 3 - 8 days |  | Profile |  |  |  |  | Focus Diagnositics, Inc.
FMEPL | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FMEPL | Billing Component | FMEPL |  | HERPES SIMPLEX TEST |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86695
FMEPL | Billing Component | FMEPL |  | HERPES SIMPLEX TYPE 2 |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86696
FMEPL | Billing Component | FMEPL |  | HERPES SIMPLEX TYPE 2 |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86696
FMEPL | Billing Component | FMEPL |  | MUMPS ANTIBODY |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86735
FMEPL | Billing Component | FMEPL |  | WEST NILE VIRUS ANTIBODY |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86789
FMEPL | Billing Component | FMEPL |  | HERPES SIMPLEX TEST |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86695
FMEPL | Billing Component | FMEPL |  | WEST NILE VIRUS AB IGM |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86788
FMEPL | Billing Component | FMEPL |  | LYMPH CHORIOMENINGITIS AB |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86727
FMEPL | Billing Component | FMEPL |  | ENCEPHALITIS ANTIBODY |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86652
FMEPL | Billing Component | FMEPL |  | ENCEPHALITIS ANTIBODY |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86651
FMEPL | Billing Component | FMEPL |  | ENCEPHALITIS ANTIBODY |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86654
FMEPL | Billing Component | FMEPL |  | ENCEPHALITIS ANTIBODY |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86653
FMEPL | Component | FMAPC | Mumps Antibody Panel, IFA CSF | Mumps Antibody Panel, IFA CSF | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  | 2 | 86735 |  |  | Yes | No
FMAPC | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FMAPC | Result | Z2891 | [NAME] IgG, IFA | [NAME] IgG, IFA | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMAPC | Result | Z2892 | Mumps Ab IgM, IFA | Mumps Ab IgM, IFA | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMAPC | Result | Z2893 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FLCVC | LCM Virus Ab, IFA CSF | LCM Virus Ab, IFA CSF | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  | 2 | 86727 |  |  | Yes | No
FLCVC | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FLCVC | Result | Z2888 | LCM IgG | LCM IgG | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FLCVC | Result | Z2889 | LCM IgM | LCM IgM | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FLCVC | Result | Z2890 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FEEEV | [NAME], IFA CSF | [NAME], IFA CSF | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  | 2 | 86652 |  |  | Yes | No
FEEEV | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FEEEV | Result | Z2880 | Eastern [NAME] | Eastern [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FEEEV | Result | Z2881 | Eastern Equine IgM | Eastern Equine IgM | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FEEEV | Result | Z2882 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FCEVP | Calif Enceph Virus Ab Pnl, IFA CSF | California Encephalitis Ab Panel, CSF | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  | 1 | 86651 |  |  | Yes | No
FCEVP | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FCEVP | Result | Z2877 | California IgG | California IgG | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FCEVP | Result | Z2878 | California IgM | California IgM | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FCEVP | Result | Z2879 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FSLEV | St. Louis Encephalitis Ab, IFA CSF | St Louis Encephalitis Ab, IFA (CSF) | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  | 2 | 86653 |  |  | Yes | No
FSLEV | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FSLEV | Result | Z2894 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FSLEV | Result | Z2895 | St Louis IgM | St Louis IgM | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FSLEV | Result | Z2896 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FWEQE | [NAME], IFA CSF | [NAME], IFA CSF | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  | 2 | 86654 |  |  | Yes | No
FWEQE | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FWEQE | Result | Z2897 | Western [NAME] | Western [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FWEQE | Result | Z2898 | Western Equine IgM | Western Equine IgM | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49082-1 | Western equine encephalitis virus Ab.IgG & IgM:Imp:Pt:Ser:Nom:
FWEQE | Result | Z2899 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | [NAME] | West Nile Virus Antibodies (IgG, IgM), CSF | West Nile Virus Ab (IgG, IgM), CSF | Only orderable as part of FMEPL Enzyme Immunoassay (EIA) |  |  |  |  |  | Only orderable as part of FMEPL |  |  | See profile FMEPL for reference range information |  |  |  |  | Profile |  |  | Yes | No
[NAME] | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
[NAME] | Result | Z3241 | West Nile Ab IgG, CSF | West Nile Ab IgG, CSF | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
[NAME] | Result | Z3242 | West Nile Ab IgM, CSF | West Nile Ab IgM, CSF | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FHSV | HSV 1/2 IgG Type-Specific Ab, CSF | HSV 1/2 IgG Type-Specific Ab, CSF | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  |  | Profile |  |  | Yes | No
FHSV | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FHSV | Result | Z2886 | HSV 1 IgG Index | HSV 1 IgG Index | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FHSV | Result | Z2887 | HSV 2 IgG Index | HSV 2 IgG Index | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | Component | FHSVA | HSV 1/2 IgM Ab IFA Reflex to [NAME] | HSV 1/2 IgM Ab IFA Reflex to [NAME] | Only orderable as part of FMEPL |  |  |  |  |  | Only orderable as part of FMEPL |  |  |  |  |  |  |  | Profile |  |  | Yes | No
FHSVA | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FHSVA | Result | Z2900 | HSV 1 IgM Screen | HSV 1 IgM Screen | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FHSVA | Result | Z2901 | HSV 2 IgM Screen | HSV 2 IgM Screen | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | [NAME] | FMTR1 | HSV 1 IgM Titer | HSV 1 IgM Titer | Immunofluorescence Assay (IFA)   Only orderable as a reflex from FMEPC and FMCPL and FENAB |  |  |  |  |  | Only orderable as a reflex from FMEPC and FMCPL and FENAB |  |  |  |  |  |  |  | Profile |  |  | No | No
FMTR1 | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FMTR1 | Result | Z2957 | HSV 1 IgM Titer | HSV 1 IgM Titer | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMEPL | [NAME] | FMTR2 | HSV 2 IgM Titer | HSV 2 IgM Titer | Immunofluorescence Assay (IFA)   Only orderable as a reflex from FMEPC and FMCPL and FENAB |  |  |  |  |  | Only orderable as a reflex from FMEPC and FMCPL and FENAB |  |  |  |  |  |  | 1 | 86696 |  |  | No | No
FMTR2 | [NAME] | CSF | CSF |  |  |  | Refrigerated | 7 days
FMTR2 | Result | Z2958 | HSV 2 IgM Titer | HSV 2 IgM Titer | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process